M&A Deal Summary

Celmed BioSciences Acquires NewBiotics

On July 2, 2004, Celmed BioSciences acquired healthcare services company NewBiotics

Acquisition Highlights

This is Celmed BioSciences’ 1st transaction in the Healthcare Services sector.
This is Celmed BioSciences’ 1st transaction in the United States.
This is Celmed BioSciences’ 1st transaction in California.

M&A Deal Summary
Date	2004-07-02
Target	NewBiotics
Sector	Healthcare Services
Buyer(s)	Celmed BioSciences
Deal Type	Add-on Acquisition

Target

NewBiotics

San Diego, California, United States

NewBiotics Inc., is a biopharmaceutical developer of cancer therapies.

Search 215,058 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Buyer(S) 1

Buyer

Celmed BioSciences

Saint-Laurent, Canada

Category	Company
Founded	2001
Sector	Life Science

DESCRIPTION

Celmed develops photodynamic-based therapies to treat hematological and immune diseases using its proprietary technology Theralux(TM).

DEAL STATS	#
Overall	1 of 1
Sector: Healthcare Services M&A	1 of 1
Type: Add-on Acquisition M&A Deals	1 of 1
State: California M&A	1 of 1
Country: United States M&A	1 of 1
Year: 2004 M&A	1 of 1